Ares Management Corporation

ticker: ARES step: 01 generated: 2026-05-28 source: coverage-next-full (transcript-free)

Ares Management (ARES) — Step 01: Business Model & Value-Chain Map

Key Findings

ARES is a global alternative asset manager that monetizes investor capital through three fee mechanics: (1) management fees on AUM (~78% of fee-related revenue, recurring), (2) realized performance income / carried interest (~17%, lumpy and harvest-dependent), and (3) Aspida insurance / investment income (~5%, growing structural [S2][S4][S7]). Four investment groups: Credit (65% of AUM), Real Assets (22%, doubled post-GCP), Secondaries (7%), Private Equity (4%) [S2]. The business is structurally levered to: long-duration capital (locked-up drawdown funds and perpetual capital), high incremental margins on incremental AUM, and the maturation of the Aspida insurance flywheel. Net positive for thesis — the business model is durable, scalable, and the perpetual-capital build-out is the key strategic asset to track.

Implications for Thesis and Valuation

1. Management fees are the durable cash engine (~$3.7B FY2025 [S2]) — these grow with FPAUM at ~22% CAGR and don't compress meaningfully (vs. traditional active managers where fee rates are eroding 1-2bps/year).
2. Performance income is the variance source — Q4 2025 missed because performance harvest timing slipped; the long-cycle carry pool (NAPI) is the buffer.
3. Aspida is under-modeled in consensus — at maturity (5+ years), Aspida could provide $50B+ of captive credit deployment, materially increasing the AUM compounding rate beyond third-party fundraising alone.
4. Real Assets segment optionality — Doubled in 2025 (GCP). FY2026 will reveal whether GCP synergies are real (positive thesis input) or whether GCP integration generates margin drag (negative input).
5. The model is capital-light in steady state but acquisition-heavy in growth phase (GCP, Crescent Point, Landmark, Black Creek, Aspida build-out).

Objective

Map the ARES business model, identify how each fee mechanism produces shareholder economics, and characterize value-chain position relative to LPs, portfolio companies, and the broader alternative asset ecosystem.

Narrative Analysis

What ARES Does

ARES raises capital from institutional LPs (pension funds, sovereign wealth, insurance companies, endowments) and increasingly from wealth-channel retail investors. It invests this capital through dedicated investment vehicles (drawdown funds, perpetual capital structures, BDCs, interval funds, etc.) and earns:

1. Management fees — Typically 75-150 bps annually on FPAUM. Blended effective fee rate ≈ 95-100 bps [A09]. These are contractual, recurring, and accrue regardless of investment performance during the fund's life.
2. Performance fees / carried interest — A share (typically 10-20%) of investment profits above a preferred return threshold (typically 6-8% IRR). Recognized when funds realize gains via portfolio company exits, refinancings, dispositions. The accrued-but-unrealized portion appears on the balance sheet as Net Accrued Performance Income (NAPI), historically $1.0-1.2B at quarter-end [S2].
3. Aspida investment income — Aspida originates fixed annuities, deploys proceeds into Ares-managed credit strategies, and earns the spread. ARES captures both the management fee on Aspida's deployed capital AND a share of Aspida's net investment spread [S5][S15].

Value Chain Position

Capital Sources                Ares Management Platform           Deployment / Borrowers
─────────────────              ─────────────────────────          ──────────────────────
Institutional LPs              ┌────────────────────────┐
(pension, sovereign,           │  Credit Group ($407B)  │ ─────►  US/EU mid-mkt
endowment, insurance)          │  - Direct Lending      │         leveraged loans,
                               │  - Alt Credit          │         CLOs, opportunistic
Wealth channel /          ────►│  - High Yield/Liquid   │         credit
retail investors               │  - CLOs                │
(via interval funds,           ├────────────────────────┤
non-traded BDCs)               │  Real Assets ($139B)   │ ─────►  Real estate (equity
                               │  - RE Equity + Debt    │         + debt), infra debt,
ARES balance sheet         ───►│  - Infrastructure      │         climate infra,
(via Aspida fixed annuities,   │  - Climate Infra       │         post-GCP Asia
employee co-invest)            ├────────────────────────┤
                               │  Secondaries ($42B)    │ ─────►  LP secondaries +
                               │  - LP-led              │         GP continuation
                               │  - GP-led continuation │         vehicles
                               ├────────────────────────┤
                               │  Private Equity ($25B) │ ─────►  Mid-mkt PE +
                               │  - Mid-Mkt PE          │         special opp PE
                               │  - Special Opp         │
                               └────────────────────────┘

   ARES extracts:              ARES employs ~3,200       Returns capital +
   - Mgmt fees on FPAUM        people across origination,  performance to LPs
   - Realized perf income      portfolio mgmt, distribution
   - Aspida net spread         + functional support
   - Aspida BS earnings (NCI)

The Aspida Flywheel — Strategic Centerpiece

ARES acquired Aspida (then a small insurance platform) and progressively built it into a fixed-annuity reinsurance business. The flywheel:

1. Aspida issues fixed-rate annuities to retail investors → permanent liability with multi-decade duration
2. Aspida invests proceeds into Ares Credit Group strategies → ARES earns management fees on this captive capital
3. Aspida earns the net spread between annuity rate (~5%) and Ares-deployed credit yields (~8-10%)
4. Both the management fee AND the spread accrue to ARES economics

This is structurally analogous to Apollo/Athene ($300B+ insurance flywheel) and KKR/Global Atlantic ($200B). Aspida is currently smaller ($15-20B+) but growing rapidly [S2][S5][S15]. Critically: Aspida-deployed AUM is "perpetual capital" by definition — annuity liabilities don't redeem like LP fund commitments.

Perpetual Capital — The Margin Multiplier

Perpetual capital AUM reached $200B at YE2025 (32% of total), growing 50% YoY [S2]. Sources:

• Ares Capital Corp (ARCC) — the largest publicly-traded BDC; permanent capital structure
• Aspida insurance balance sheet (above)
• Ares Strategic Income Fund (ASIF) — interval fund
• Ares Industrial Income Fund (AIIF) — interval fund / NTREIT
• AREIT (non-traded REIT vehicles)
• Core+ / open-end real estate funds
• GP-led continuation vehicles (some perpetual)

Strategic importance: perpetual capital eliminates the "fundraising treadmill" that traditional drawdown funds require. Once raised, perpetual capital compounds management fees indefinitely without LP redemption risk. Best-in-class alts manager (Blue Owl/OWL) operates at ~80% perpetual; ARES at 32% has significant room to inflect [S7].

Where Margin Comes From

• Management fees flow to a structurally high-margin business — incremental AUM doesn't require linear headcount growth
• FRE margin 41.7% FY2025 [S8]; BX achieves 60%+ at scale [Peer Universe]
• Path to higher FRE margin: scale on existing platform + slower headcount growth than AUM growth
• Performance-fee revenue ~50% offset by perf-fee comp — only half is net economic value to shareholders [S2]
• Aspida investment income drops through with high incremental margin (spread is fairly clean)

Secondary Track Consideration

ARES has an insurance subsidiary (Aspida) and significant insurance-cycle exposure on a consolidated basis. However, the dominant economics are asset management fees and carry, not insurance underwriting. The Asset Manager — Alternative track is unambiguously primary. The insurance dimension is a key feature (flywheel) but does not warrant a primary insurer track.

Evidence and Sources

• Segment AUM at YE2025: Credit $406.9B, Real Assets $139.1B, Secondaries $42.1B, PE $25.3B [S2]
• Capital raised FY2025: $113.2B across 190+ vehicles [S2]
• Capital deployed FY2025: $145.8B including $69.1B from drawdown funds [S2]
• Q1 FY2026 fundraising: ~$29.5B (record quarter); $20.4B (69%) to Credit [S4]
• Perpetual capital growth: $133B (YE24) → $200B (YE25) → $215B (Q1 26) [S2][S4]
• Management fees crossed $1B in a single quarter for first time in Q1 2026 [S4]

Assumption Register Updates

New entries: A05 (Credit Group dominance), A06 (GCP doubling Real Assets). See ARES_assumption_register.md.

Tables and Calculations

Revenue Mix Estimate (FY2025)

(Note: GAAP "Total Revenues" in XBRL approximately equal to the sum of fee-related streams here — broadly consistent.)

Customer / LP Concentration

ARES discloses limited LP concentration data; the above is industry-typical for a top-5 alts manager.

Geographic Mix (FY2025 post-GCP)

Pre-GCP this was ~80% North America, ~15% Europe, ~5% Other. GCP shifted the geographic mix toward Asia.

Open Questions and Data Gaps

1. Aspida total assets and projected scale path — Granular disclosure limited; need to triangulate from consolidated B/S movements
2. Performance fee cadence by fund vintage — Material for forecasting; not in summary supplements
3. GCP cost-synergies trajectory — Not yet quantified by management
4. Wealth-channel AUM precise breakdown — Growing but exact share unclear

Next-Step Dependencies

Step 02 (industry/competitive) will leverage the four-segment and Aspida-flywheel framing established here. Step 03 (revenue architecture) will quantify the fee-rate by segment. Step 06 (balance sheet) will assess Aspida consolidation impact.

Source Index

ticker: ARES step: 12 generated: 2026-05-28 source: coverage-next-full (transcript-free)

ARES — Step 12: Bull vs Bear — Analyst Debate Synthesis

Key Findings

ARES sits at a clear bull-vs-bear inflection as of late May 2026: the bull thesis is durable ~20% AUM/DE CAGR, perpetual capital inflection through 40%+, Aspida flywheel maturation, and a record Q1 26 fundraising print [S4] vs the bear thesis of private-credit overcapacity / "$265B meltdown" multiple compression [S11], FRE margin creep risk, and Up-C/TRA cash leakage. The stock trades at ~14× P/DE versus a peer median of 16-22× [S12][S15] — implying the bear case is partly priced in, but not fully. Consensus 12-month target is ~$179 (vs $108 spot in early May 2026 = ~66% upside) [S12] — sell-side modally constructive but with high dispersion. The variant perception (per Step 16) is that the market is under-pricing ARES's perpetual capital inflection and Aspida flywheel — these are slow-build optionality that compounds over 3-5 years. Net constructive bias on the multi-year horizon, with credit-cycle clarity required for full conviction in the 12-month frame.

Implications for Thesis and Valuation

1. Probability-weighted scenarios: Bull 35% × $200+ + Base 45% × $150-170 + Bear 20% × $90-110 = Expected value ~$155 (vs $108 spot ≈ +44%).
2. Multi-year (3-5 year) thesis is stronger than 12-month — perpetual capital + Aspida maturation are time-dependent value drivers.
3. Entry timing matters — at $108 the risk/reward is favorable but credit-cycle clarity (a few more quarters of fundraising data + private credit fund stability) would tighten the bear case.
4. The bear case is largely sector-wide, not ARES-specific — which both limits ARES-specific catalyst risk and means ARES rallies on sector recovery.
5. Q4 26 / FY26 carry-harvest cycle is the most material near-term catalyst — management has signaled FY26 should be a strong harvest year [S2].

Objective

Synthesize the bull-vs-bear analyst debate using filings, press releases, consensus commentary, and sector news (no transcripts loaded). Frame the debate so that Step 15 (scenarios under /complete-coverage) can build out the explicit scenario analysis.

Narrative Analysis

What the Bulls Believe

Core bull thesis (composite from sell-side notes, public.com / etoro analyst views, AGM Alts Weekly [S12][S15]):

1. AUM growth at ~20% CAGR is durable through FY28 — record Q1 26 fundraising ($29.5B) + shadow AUM ($80B+) + perpetual capital additions provide multi-year fee-revenue visibility [S4].

2. Perpetual capital inflection — moving from 32% (YE25) to management aspiration of 40%+ over 3-5 years would materially de-risk the fee base and warrant a higher multiple. The market has not fully priced this.

3. FRE margin holds or expands — currently 41-43%; operating leverage on incremental FPAUM at 80%+ marginal margin → FY27-28 FRE margin could reach 45%+.

4. Aspida insurance flywheel — sub-scale today (~$15-20B) vs APO/Athene ($300B+) but trajectory is right. At maturity, Aspida adds ~$300-500M of incremental annualized revenue.

5. GCP integration delivers synergies — FY26 first full year; cross-selling + scale benefits in Real Assets + Asia footprint creates incremental fee revenue.

6. Capital allocation discipline — 22% dividend CAGR, no goodwill impairments, accretive M&A track record.

7. Multiple should re-rate — ARES at 14× P/DE is below peer median 16-22×; sector recovery from the private-credit overhang should lift multiples toward 16-18× range.

Bull case target: $200+ (+85%+ upside from $108).

What the Bears Believe

Core bear thesis (composite from Fortune coverage, Simply Wall Street margin-compression flags, bear-side sector commentary [S11][S15]):

1. Private credit cycle stress is real and worsening — Fortune's "$265B meltdown" is the leading sector narrative; if specific ARES-managed funds run into NAV / redemption stress (none publicly identified yet, but ARES has $400B+ credit AUM = lots of fund-level potential exposure), multiples re-rate down sharply.

2. Direct-lending spread compression — 25-75 bps over 18-24 months means $300M-$700M revenue impact on a $300B+ direct-lending FPAUM base. Material to FRE.

3. FRE margin compression risk — Simply Wall Street flagged incentive comp ratio creep in Q1 26; if this trend continues, FRE margin could erode toward 38-40% over 4-6 quarters.

4. Up-C / TRA cash leakage — ~$50-100M/yr drag on cash-economic returns; DE overstates true returns to common.

5. Insider activity neutral-to-negative — 0 open-market buys during the March 2026 drawdown when stock was at ~$95 = no management conviction signal.

6. Industry overcapacity is fundamental, not cyclical — too much LP capital allocated to alts (~25% target vs ~10% historic); risk of LP allocation moderation if 1-2 years of mediocre returns materialize.

7. Aspida lag vs APO/Athene — ARES is materially behind the curve on insurance flywheel; this is not a near-term catalyst.

Bear case target: $90-110 (flat to -15% from $108).

Variant Perception (preview of Step 16)

Market under-pricing:

• Aspida flywheel maturation (3-5 year compounding)
• Perpetual capital % of AUM crossing 40% inflection
• Shadow AUM ($80B+) providing 12-18 months fee-revenue visibility
• GCP cross-selling synergies (FY26-27)

Market over-pricing (i.e., bear is partially right):

• ARES's resilience to private-credit cycle
• FRE margin sustainability at 42%+

The variant view: market is conflating ARES's sector-wide multiple compression with ARES-specific fundamental risk, when in fact ARES's fundamental drivers are intact and the perpetual capital / Aspida optionality is real.

Near-Term Catalysts (12-Month)

Consensus Frame

Consensus expects multi-year multiple expansion AND DE/sh growth.

Synthesis

The bull and bear cases are both partially right. The bull's emphasis on durable platform fundamentals + perpetual capital inflection + Aspida flywheel is supported by Q1 26 data and the 3-5 year structural setup. The bear's emphasis on credit-cycle stress + FRE margin creep + multiple compression risk is supported by sector data and reasonable concerns about NAV / spread dynamics.

The disagreement is largely about the time-horizon and resolution path:

• Multi-year (3-5 years) — bulls have the edge on structural drivers
• 12-month (FY26) — heavily dependent on credit-cycle resolution

Recommended stance (anticipating Step 18): Constructive multi-year thesis at current ~$108; appropriate sizing reflects credit-cycle uncertainty; add aggressively on credit-cycle clarity or further weakness toward $90-100.

Evidence and Sources

• Private credit panic: Fortune March 2026 [S11]
• Q1 26 fundraising record: ARES Q1 26 release [S4]
• Consensus target + rating distribution: public.com / etoro / stockanalysis aggregated [S12]
• FRE margin trajectory: Q4 25 + Q1 26 releases [S4][S8]
• Margin compression watch: Simply Wall Street post-Q1 26 [S15]
• Insider activity: SEC Form 4 [S10]

Assumption Register Updates

Existing A25 (Bull case AUM CAGR 18-22%) and A26 (Bear case AUM CAGR 5-10%) anchor scenarios. No new entries.

Tables and Calculations

See bull thesis breakdown, bear thesis breakdown, catalyst table, and consensus frame above.

Open Questions and Data Gaps

1. Magnitude of any specific ARES-managed credit fund stress — None publicly identified but ARES manages 200+ funds; tail risk exists
2. GCP synergy quantification — Will not be fully visible until late FY26
3. Fed rate cut path — Currently ~150 bps of cuts priced in FY26; outcome uncertain
4. LP allocation shift in 2026-2027 — Sustainability of ~25% target allocation TBD

Next-Step Dependencies

Step 16 (variant perception) deepens the under-pricing and over-pricing analysis. Step 15 (scenarios under /complete-coverage) builds explicit quantitative scenarios. Step 18 (portfolio fit) translates bull-bear synthesis into position sizing and entry-timing recommendations.

Source Index

Bull Case — 3 bullets

1. Durable ~20% AUM / DE CAGR through FY28. Record Q1 26 fundraising ($29.5B, +48% YoY) + $80B+ shadow AUM + perpetual capital additions provide multi-year fee-revenue visibility. FRE +26% YoY at $464.4M shows operating leverage intact [S4]. AUM trajectory to ~$1T over 3-5 years is plausible.

2. Perpetual capital inflection 32% → 40%+ over 3-5 years would warrant a 20%+ multiple re-rating. ARES currently trades at ~14× P/DE vs peer median 16-22×; OWL at 80% perpetual capital trades at 22× — the perpetual capital math drives sustained re-rating [S12][S15]. Aspida flywheel ($15-20B → $40-50B+) adds incremental durable revenue.

3. GCP synergies + Asia momentum + carry-harvest cycle hit in FY26. First full year of GCP International contribution doubles Real Assets AUM impact; carry-harvest cycle expected to be strong; cross-selling between ARES and GCP LP bases delivers additional fundraising tailwind. Capital allocation discipline (22% dividend CAGR, no impairments, accretive M&A) supports the thesis [S2][S14].

Bear Case — 3 bullets

1. Private credit cycle stress and the "$265B meltdown" narrative compress multiples sector-wide. Direct-lending spread compression of 25-75 bps over 18-24 months → $300M-$700M revenue impact on $300B+ direct-lending FPAUM base; LP allocation appetite could moderate if 1-2 years of mediocre sector returns materialize. ARES at 14× P/DE may re-rate down further toward 11-13× if specific ARES-managed credit funds run into NAV / redemption stress [S11][A23].

2. FRE margin compression from rising incentive comp ratios. Simply Wall Street flagged Q1 26 incentive comp ratio creep — if this trend continues, FRE margin could erode from 41-43% toward 38-40% over 4-6 quarters, materially compressing the operating leverage thesis [S15]. The Q4 25 miss already showed performance harvest timing variance is a real downside risk.

3. Up-C / TRA cash leakage + lack of insider conviction signal mild bear. ~$50-100M/yr TRA payments are real cash drag that DE overstates; ongoing AOG unit exchanges + ~$1B Series B Preferred conversion add per-share dilution; insider 0 open-market buys during the March 2026 drawdown when stock traded ~$95 = no management conviction signal at currently mid-range valuation [S9][S10]. Aspida lag vs APO/Athene means insurance flywheel is not a near-term catalyst.